Erectile dysfunction after therapy with metoprolol: the Hawthorne effect.

Area of Science:

• Cardiology
• Pharmacology
• Psychology

Background:

• Beta-blockers like metoprolol (METO) are often assumed to cause erectile dysfunction (ED) in men.
• However, the direct pharmacological role of METO in ED is not well-established, with cardiovascular disease and psychological factors also implicated.
• This study investigates the specific contribution of METO to ED in hypertensive patients.

Purpose of the Study:

• To determine if metoprolol (METO) pharmacologically causes erectile dysfunction (ED) or if psychological factors contribute significantly.
• To assess the impact of patient information and expectation on the incidence of ED.
• To compare the efficacy of tadalafil and placebo in treating drug-induced ED.

Main Methods:

• 114 hypertensive men without ED were randomized into three groups based on information about metoprolol (METO) and potential ED side effects.
• Group 1 was fully informed, Group 2 partially informed, and Group 3 uninformed.
• The incidence of ED was recorded after 60 days, followed by a cross-over phase comparing tadalafil and placebo for ED treatment.

Main Results:

• The incidence of ED was significantly higher in fully informed patients (32%) compared to partially informed (13%) and uninformed groups (8%).
• Both tadalafil and placebo were equally effective in treating the ED that occurred.
• This suggests a strong psychological component, likely the Hawthorne effect, contributing to ED.

Conclusions:

• Patient expectation and the Hawthorne effect play a significant role in the occurrence of erectile dysfunction (ED) associated with metoprolol (METO).
• The psychological nature of this METO-induced ED means placebo is as effective as tadalafil in its reversal.
• This highlights the importance of managing patient expectations regarding drug side effects.